Skip to main content
logo
BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
8.49
-0.16 (-1.85%)
Sep 11, 2026, 4:00 PM EDT - Market closed

BioAge Labs Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
390474208--
Market Cap Growth
125.50%128.54%---
Enterprise Value
11186-117--
Last Close Price
8.4913.235.79--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
37.6352.74---
PB Ratio
1.041.740.64--
P/TBV Ratio
1.041.740.64--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
1.0920.64---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.020.03-1.310.12
Net Debt / Equity Ratio
-1.01-1.03-1.07-0.78-1.25
Net Debt / EBITDA Ratio
3.573.024.43-0.650.63
Net Debt / FCF Ratio
4.303.406.66-0.840.69
Asset Turnover
0.030.03---
Quick Ratio
16.7514.0612.800.374.72
Current Ratio
17.1914.2412.860.444.78
Return on Equity (ROE)
-28.21%-27.09%-50.35%--
Return on Assets (ROA)
-18.47%-17.76%-25.44%-111.31%-
Return on Capital Employed (ROCE)
-28.10%-33.80%-23.70%150.10%-177.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-24.24%-16.99%-34.26%--
FCF Yield
-22.61%-17.36%-25.00%--
Buyback Yield / Dilution
-43.28%-234.99%-541.23%-0.06%-
SEC Filings: 10-K · 10-Q